Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Ozakbas · SciRah

Researcher profile · Semantic Scholar

S. Ozakbas

Share profile

S. Ozakbas — researcher profile on SciRah

h-index: 29
Works: 255
Citations: 3,093

Most-cited papers

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
J. Müller, S. Sharmin, J. Lorscheider, S. Ozakbas +93 more
2025JAMA Neurology57 citations Open access
Semantic Scholar
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
T. Kalincik, S. Sharmin, Izanne Roos, M. Freedman +56 more
2023JAMA Neurology54 citations Open access
Semantic Scholar
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
Chao Zhu, T. Kalincik, D. Horáková, Zhen Zhou +38 more
2023JAMA Neurology39 citations Open access
Semantic Scholar
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries.
S. Sharmin, Izanne Roos, C. Malpas, P. Iaffaldano +16 more
2024The Lancet Child & Adolescent Health34 citations Open access
Semantic Scholar
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
S. Sharmin, Izanne Roos, S. Simpson-Yap, C. Malpas +88 more
2023Brain : a journal of neurology22 citations Open access
Semantic Scholar
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
Y. Foong, Daniel Merlo, M. Gresle, K. Buzzard +19 more
2024Journal of Neurology Neurosurgery & Psychiatry21 citations
Semantic Scholar
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Izanne Roos, S. Sharmin, C. Malpas, S. Ozakbas +42 more
2024Multiple Sclerosis21 citations Open access
Semantic Scholar
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
Wei Z. Yeh, A. van der Walt, O. Skibina, T. Kalincik +46 more
2024Neurology(R) neuroimmunology & neuroinflammation20 citations Open access
Semantic Scholar
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis
T. Spelman, G. Simoneau, R. Hyde, R. Kuhelj +19 more
2024Neurology19 citations Open access
Semantic Scholar
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.
P. Siriratnam, S. Huda, A. van der Walt, Paul G. Sanfilippo +26 more
2024Neurology19 citations
Semantic Scholar
The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
C. Boz, S. Ozakbas, M. Terzi, R. Karabudak +16 more
2023Neurological Sciences19 citations Open access
Semantic Scholar
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
C. Daruwalla, V. Shaygannejad, S. Ozakbas, E. Havrdová +88 more
2023Multiple Sclerosis14 citations Open access
Semantic Scholar
Feasibility of Telerehabilitation-Based Pelvic Floor Muscle Training for Urinary Incontinence in People With Multiple Sclerosis: A Randomized, Controlled, Assessor-Blinded Study
Ipek Yavas, T. Kahraman, O. Sagici, A. T. Ozdogar +3 more
2023Journal of Neurologic Physical Therapy14 citations
Semantic Scholar
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
P. Siriratnam, Paul G. Sanfilippo, A. van der Walt, S. Sharmin +28 more
2024Journal of Neurology Neurosurgery & Psychiatry13 citations Open access
Semantic Scholar
Risk of secondary progressive multiple sclerosis after early worsening of disability
W. Dzau, S. Sharmin, F. Patti, G. Izquierdo +23 more
2023Journal of Neurology Neurosurgery & Psychiatry13 citations
Semantic Scholar
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data
A. Pirmani, E. De Brouwer, A. Arany, M. Oldenhof +69 more
2025npj Digital Medicine12 citations Open access
Semantic Scholar
Manifestations of walking fatigability in people with multiple sclerosis based on gait quality and distance walked during the six minutes walking test.
F. B. Santinelli, Zuhal Abasıyanık, C. Ramari, G. Gysemberg +6 more
2024Multiple Sclerosis and Related Disorders12 citations
Semantic Scholar
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Anoushka Lal, YiChao Foong, Paul G. Sanfilippo, T. Spelman +51 more
2024Journal of Neurology11 citations Open access
Semantic Scholar
Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment.
S. Şen, A. Tuncer, M. Terzi, S. D. Bünül +9 more
2023Multiple Sclerosis and Related Disorders10 citations
Semantic Scholar
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
I. Diouf, C. Malpas, S. Sharmin, Izanne Roos +54 more
2023Journal of Neurology Neurosurgery & Psychiatry10 citations Open access
Semantic Scholar
Effect of Telerehabilitation-Based Motor Imagery Training on Pain and Related Factors in People with Multiple Sclerosis: Randomized Controlled Pilot Trial.
H. Karakaş, T. Kahraman, A. T. Ozdogar, C. Baba +1 more
2024Archives of Physical Medicine and Rehabilitation9 citations
Semantic Scholar
Persistent progression independent of relapse activity in multiple sclerosis
Chao Zhu, Zhen Zhou, T. Kalincik, Izanne Roos +41 more
2025Brain Communications7 citations Open access
Semantic Scholar
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.
T. Kalincik, S. Sharmin, Izanne Roos, M. Freedman +45 more
2025Brain : a journal of neurology7 citations Open access
Semantic Scholar
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis
YiChao Foong, Daniel Merlo, M. Gresle, K. Buzzard +38 more
2025Journal of Neurology Neurosurgery & Psychiatry7 citations
Semantic Scholar
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study
D. Levitz, Yi Chao Foong, Paul G. Sanfilippo, T. Spelman +37 more
2024Therapeutic Advances in Neurological Disorders7 citations Open access
Semantic Scholar
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
I. Diouf, C. Malpas, S. Sharmin, Izanne Roos +78 more
2023European Journal of Neurology7 citations Open access
Semantic Scholar
Disability accrual in primary and secondary progressive multiple sclerosis
Sam Harding-Forrester, Izanne Roos, A. Nguyen, C. Malpas +68 more
2023Journal of Neurology Neurosurgery & Psychiatry7 citations Open access
Semantic Scholar
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
Simona Toscano, T. Spelman, S. Ozakbas, R. Alroughani +54 more
2025Neurotherapeutics6 citations Open access
Semantic Scholar
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability
Jessica Shipley, Heidi N. Beadnall, Paul G. Sanfilippo, Wei Z. Yeh +35 more
2025JAMA Network Open6 citations Open access
Semantic Scholar
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry
A. Signori, M. Ponzano, T. Kalincik, S. Ozakbas +16 more
2024Journal of Neurology Neurosurgery & Psychiatry6 citations
Semantic Scholar
The relationship between work difficulties and physical disability, cognitive and social cognitive impairment and subcortical gray matter atrophy in persons with multiple sclerosis
T. Aslan, A. T. Ozdogar, O. Sagici, S. Ozakbas
2024Acta Neurologica Belgica6 citations
Semantic Scholar
Dual‐task difficulties as a risk factor for unemployment in people with multiple sclerosis
T. Kahraman, Hasretgul Temiz, Zuhal Abasıyanık, C. Baba +1 more
2023Brain and Behavior6 citations Open access
Semantic Scholar
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
T. Spelman, W. L. Herring, C. Acosta, R. Hyde +61 more
2023Journal of Medical Economics6 citations Open access
Semantic Scholar
Narrative review based on fingolimod therapy in pediatric MS
Bilge Piri Çınar, B. Konuşkan, B. Anlar, S. Ozakbas
2023SAGE Open Medicine6 citations Open access
Semantic Scholar
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study.
H. Butzkueven, Pamela A. Farr, S. Ozakbas, C. Boz +22 more
2025Multiple Sclerosis and Related Disorders5 citations Open access
Semantic Scholar
Prevalence of distance walking fatigability in multiple sclerosis according to MS phenotype, disability severity and walking speed.
F. B. Santinelli, Zuhal Abasıyanık, U. Dalgas, S. Ozakbas +9 more
2024Annals of Physical and Rehabilitation Medicine5 citations Open access
Semantic Scholar
Comparative effectiveness in multiple sclerosis: A methodological comparison
Izanne Roos, I. Diouf, S. Sharmin, D. Horáková +67 more
2023Multiple Sclerosis5 citations Open access
Semantic Scholar
Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.
S. Ozakbas, E. Kaya, T. Aslan, A. T. Ozdogar +1 more
2024Multiple Sclerosis and Related Disorders4 citations
Semantic Scholar
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Ying Li, A. Saul, B. Taylor, A. Ponsonby +152 more
2023Journal of Neurology4 citations Open access
Semantic Scholar
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
A. Souissi, F. Patti, T. Spelman, C. Chisari +79 more
2026Journal of Neurology3 citations Open access
Semantic Scholar
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry
E. Gómez-Figueroa, Patricia Orozco-Puga, C. Corona-Vázquez, C. Moreno-Bernardino +38 more
2025Therapeutic Advances in Neurological Disorders3 citations Open access
Semantic Scholar
The role of pregnancy in relapsing-remitting MS prognosis: A five-year study.
E. Kaya, T. Aslan, Y. Şimşek, Sinem Ozcelik +1 more
2025Multiple Sclerosis and Related Disorders3 citations
Semantic Scholar
Predicting disease progression in multiple sclerosis with clinically accessible information and technology
T. Fuchs, M. Schoonheim, E. Strijbis, Julia R. Jelgerhuis +71 more
2026Journal of Neurology2 citations Open access
Semantic Scholar
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
P. Siriratnam, S. Huda, A. van der Walt, Paul G. Sanfilippo +26 more
2025Journal of Neurology2 citations Open access
Semantic Scholar
Disease course after pregnancy in women with progressive multiple sclerosis symptoms
Jessica Shipley, Heidi N. Beadnall, Paul G. Sanfilippo, D. Horáková +16 more
2025Multiple Sclerosis2 citations Open access
Semantic Scholar
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)
V. Jokubaitis, R. Alroughani, A. Altintas, S. Eichau +36 more
2025Multiple Sclerosis2 citations Open access
Semantic Scholar
Effect of the synchronized telerehabilitation-based upper extremity training program on hand-arm functions in people with multiple sclerosis.
S. Daştan, Özge Ertekin, A. T. Ozdogar, T. Kahraman +2 more
2025Multiple Sclerosis and Related Disorders2 citations
Semantic Scholar
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years
Jodie I. Roberts, S. Sharmin, D. Horáková, Eva Kubala Havrdová +32 more
2025Journal of Neurology Neurosurgery & Psychiatry2 citations
Semantic Scholar
Explainable time-to-progression predictions in multiple sclerosis
Rob d’Hondt, Klest Dedja, Sofie Aerts, B. Van Wijmeersch +38 more
2025Comput. Methods Programs Biomed.2 citations Open access
Semantic Scholar
Predictors of relapse severity in multiple sclerosis
C. Baba, Zuhal Abasıyanık, Y. Şimşek, A. T. Ozdogar +2 more
2024Acta Neurologica Belgica2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Kalincik×36
Invite
T. Kalincik — researcher profile on SciRah
A. van der Walt×34
Invite
A. van der Walt — researcher profile on SciRah
H. Butzkueven×34
Invite
H. Butzkueven — researcher profile on SciRah
R. Alroughani×33
Invite
R. Alroughani — researcher profile on SciRah

×29

Invite

G. Laureys — researcher profile on SciRah

Invite

K. Buzzard — researcher profile on SciRah

J. Lechner-Scott×26

Invite

J. Lechner-Scott — researcher profile on SciRah

Izanne Roos×26

Invite

Izanne Roos — researcher profile on SciRah

Invite

O. Skibina — researcher profile on SciRah

Invite

C. Boz — researcher profile on SciRah

Invite

P. Mccombe — researcher profile on SciRah

Invite

O. Gerlach — researcher profile on SciRah